Aurobindo Pharma’s COVID-19 vaccine plan in limbo after partner fails to get EUA in Taiwan, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The Taiwan Food and Drug Administration (TFDA) denied EUA for UB-612 in August, citing that the vaccine failed to meet the two efficacy standards for granting EUA in its experts review, The Taiwan Food and Drug Administration (TFDA) denied EUA for UB-612 in August, citing that the vaccine failed to meet the two efficacy standards for granting EUA in its experts review, , Read More

Leave a Reply

Your email address will not be published. Required fields are marked *